FAQ - CDX: Clinical & Regulatory Alignment

Why does CDx strategy need to align with therapeutic development?
Because CDx evidence must directly support the drug’s intended use. Misalignment is a common cause of regulatory delay.

​

What evidence is expected for CDx approval in the US?
Most CDx products require PMA-level evidence linking test results to therapeutic outcomes.